Literature DB >> 10569777

Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

D A Haake1, M K Mazel, A M McCoy, F Milward, G Chao, J Matsunaga, E A Wagar.   

Abstract

New vaccine strategies are needed for prevention of leptospirosis, a widespread human and veterinary disease caused by invasive spirochetes belonging to the genus Leptospira. We have examined the immunoprotective capacity of the leptospiral porin OmpL1 and the leptospiral outer membrane lipoprotein LipL41 in the Golden Syrian hamster model of leptospirosis. Specialized expression plasmids were developed to facilitate expression of leptospiral proteins in Escherichia coli as the membrane-associated proteins OmpL1-M and LipL41-M. Although OmpL1-M expression is highly toxic in E. coli, this was accomplished by using plasmid pMMB66-OmpL1, which has undetectable background expression without induction. LipL41-M expression and processing were enhanced by altering its lipoprotein signal peptidase cleavage site to mimic that of the murein lipoprotein. Active immunization of hamsters with E. coli membrane fractions containing a combination of OmpL1-M and LipL41-M was found to provide significant protection against homologous challenge with Leptospira kirschneri serovar grippotyphosa. At 28 days after intraperitoneal inoculation, survival in animals vaccinated with both proteins was 71% (95% confidence interval [CI], 53 to 89%), compared with only 25% (95% CI, 8 to 42%) in the control group (P < 0.001). On the basis of serological, histological, and microbiological assays, no evidence of infection was found in the vaccinated survivors. The protective effects of immunization with OmpL1-M and LipL41-M were synergistic, since significant levels of protection were not observed in animals immunized with either OmpL1-M or LipL41-M alone. In contrast to immunization with the membrane-associated forms of leptospiral proteins, hamsters immunized with His(6)-OmpL1 and His(6)-LipL41 fusion proteins, either alone or in combination, were not protected. These data indicate that the manner in which OmpL1 and LipL41 associates with membranes is an important determinant of immunoprotection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569777      PMCID: PMC97069          DOI: 10.1128/IAI.67.12.6572-6582.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Leptospirosis: current developments and trends.

Authors:  A B Thiermann
Journal:  J Am Vet Med Assoc       Date:  1984-03-15       Impact factor: 1.936

4.  Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species.

Authors:  E S Shang; T A Summers; D A Haake
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic Leptospira spp.

Authors:  D A Haake; C I Champion; C Martinich; E S Shang; D R Blanco; J N Miller; M A Lovett
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

7.  Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.

Authors:  Myron Christodoulides; Joy L Brooks; Elizabeth Rattue; John E Heckels
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

8.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA.

Authors:  L F Erdile; M A Brandt; D J Warakomski; G J Westrack; A Sadziene; A G Barbour; J P Mays
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.

Authors:  G F Gerlach; C Anderson; S Klashinsky; A Rossi-Campos; A A Potter; P J Willson
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more
  84 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 2.  Spirochaetal lipoproteins and pathogenesis.

Authors:  D A Haake
Journal:  Microbiology       Date:  2000-07       Impact factor: 2.777

3.  Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins.

Authors:  David A Haake; James Matsunaga
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Subunit approach to evaluation of the immune protective potential of leptospiral antigens.

Authors:  Samuel R Félix; Daiane D Hartwig; Ana Paula C Argondizzo; Éverton F Silva; Fabiana K Seixas; Amilton C P Seixas Neto; Marco A Medeiros; Walter Lilenbaum; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

Review 5.  Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

Authors:  Karen V Evangelista; Jenifer Coburn
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

Authors:  H Guerreiro; J Croda; B Flannery; M Mazel; J Matsunaga; M Galvão Reis; P N Levett; A I Ko; D A Haake
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Genome reduction in Leptospira borgpetersenii reflects limited transmission potential.

Authors:  Dieter M Bulach; Richard L Zuerner; Peter Wilson; Torsten Seemann; Annette McGrath; Paul A Cullen; John Davis; Matthew Johnson; Elizabeth Kuczek; David P Alt; Brooke Peterson-Burch; Ross L Coppel; Julian I Rood; John K Davies; Ben Adler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

8.  Leptospiral membrane proteins--variations on a theme?

Authors:  David A Haake; James Matsunaga
Journal:  Indian J Med Res       Date:  2005-03       Impact factor: 2.375

9.  Expression and characterization of an iron-regulated hemin-binding protein, HbpA, from Leptospira interrogans serovar Lai.

Authors:  Swapna Asuthkar; Sridhar Velineni; Johannes Stadlmann; Friedrich Altmann; Manjula Sritharan
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

10.  Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.

Authors:  P C Humphryes; M E Weeks; M AbuOun; G Thomson; A Núñez; N G Coldham
Journal:  Clin Vaccine Immunol       Date:  2014-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.